Japan’s Sunshine Act unveiled

In Japan, voluntary information disclosure by the pharmaceutical industry began last year, but there have been a remarkable number of “user unfriendly” cases. In some cases, for example, people cannot print out the disclosed documents or even see the documents unless they visit the company. Some efforts are under way to change the current circumstances in which doctors rely completely on the manufacturing companies for information about medicines. To read the article by The Japan News

Read More »